| |
n cohort
|
n CAP cases
|
PY
|
IR per 100,000 PY
|
Lower 95% CI
|
Upper 95% CI
|
|---|
|
Lung cancer
|
|
Crude IR
|
11,837
|
1945
|
13,444
|
14,467.4
|
13,831.5
|
15,125.0
|
|
Standardized IRa
| |
1,256,235
|
13,188,819
|
9525.0
|
9508.4
|
9541.7
|
|
Hematological malignancies
|
|
Crude IR
|
15,317
|
1002
|
33,662
|
2976.7
|
2795.2
|
3166.8
|
|
Standardized IRa
| |
255,193
|
13,188,819
|
1934.9
|
1927.4
|
1942.4
|
|
Cancer of the gastro-intestinal tract
|
|
Crude IR
|
27,423
|
926
|
58,752
|
1576.1
|
1476.2
|
1681.0
|
|
Standardized IRa
| |
108,308
|
13,188,819
|
821.2
|
816.3
|
826.1
|
|
Renal cancer & cancer of the urinary tract
|
|
Crude IR
|
13,197
|
532
|
29,431
|
1807.6
|
1657.3
|
1968.0
|
|
Standardized IRa
| |
112,611
|
13,188,819
|
853.8
|
848.9
|
858.8
|
|
Control cohort (overall)
|
|
Crude IR
|
3,192,611
|
59,581
|
13,188,819
|
451.8
|
448.1
|
455.4
|
|
Breast cancer
|
|
Crude IR
|
22,450
|
534
|
57,359
|
931.0
|
853.7
|
1013.4
|
|
Standardized IRa
| |
45,855
|
6,647,290
|
689.8
|
683.5
|
696.2
|
|
Control cohort (breast cancer)
|
|
Crude IR
|
1,604,248
|
27,154
|
6,647,290
|
408.5
|
403.7
|
413.4
|
- aAccording to the age and sex distribution of the person time in the comparator cohort, CAP Community-acquired pneumonia, CI Confidence interval, IR Incidence rate, PY Person year
